COMMUNIQUÉS West-GlobeNewswire

Zynerba Pharmaceuticals Reports Third Quarter 2018 Financial Results and Operational Highlights
08/11/2018
DEVON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Zealand hosts conference call on November 15 at 4 pm CET (10 am EST) to present third quarter results for 2018
08/11/2018
Press Release - No. 22 / 2018 Zealand hosts conference call on November 15 at 4 pm CET (10 am EST) to present third quarter results for 2018 Copenhagen, November 8, 2018 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 [...]
Virbac : Declaration of the number of shares and voting rights as of October 2018, 31.
08/11/2018
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et de droits de vote au 31 Octobre 2018
08/11/2018
DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]
DRAFT DECISIONS OF JSC OLAINFARM EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS SUBMITTED BY INITIATORS - ANNA EMĪLIJA MALIGINA UN NIKA SAVEĻJEVA
08/11/2018
Extraordinary General Meeting of Shareholders of Joint Stock Company Olainfarm, requested by the shareholders Anna Emīlija Maligina and Nika Saveļjeva, will be held on November 22nd, 2018, at 11:00 at the premises of [...]
Interim Report, Third Quarter 2018, BioPorto Group
08/11/2018
November 8, 2018 Announcement no. 18 Highlights FDA clearance of The NGAL Test™ expected by mid-2019 In the beginning of October 2018, the U.S. Food and Drug Administration (“FDA”) requested additional data from [...]
111, Inc. Announces Third Quarter 2018 Unaudited Financial Results
08/11/2018
SHANGHAI, China, Nov. 08, 2018 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results [...]
Saniona signs option agreement with Initiator Pharma
08/11/2018
PRESS RELEASE November 8, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it has entered into a 1-year option agreement with Initiator Pharma A/S, where Initiator Pharma obtains [...]
The first patient included in PledPharma’s global Phase III program for PledOx®
08/11/2018
STOCKHOLM, November 8, 2018 — PledPharma AB (publ), a Swedish pharmaceutical developer, today announced that the first patient has been enrolled in the company’s global Phase III program with the company’s drug [...]
Financial calendar 2019
08/11/2018
Orphazyme A/S Company announcement No. 13/2018 Company Registration No. 32266355 Copenhagen, November 8, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]
ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update
08/11/2018
IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019 24-week data from Phase 2b EDELWEISS clinical trial of linzagolix in endometriosis supports 75mg without ABT and 200mg with [...]
VALNEVA Reports Nine Month Results for 2018, Confirms Guidance, Strengthens Balance Sheet with €50m Financing
08/11/2018
Valneva Reports Nine Month Results for 2018, Confirms Guidance, Strengthens Balance Sheet with €50m Financing On track to deliver on multiple key business and R&D milestones €50 million raised in oversubscribed [...]
VALNEVA publie ses résultats pour les neuf premiers mois de l'année 2018, confirme ses prévisions et renforce sa trésorerie avec une récente levée de €50m
08/11/2018
Valneva publie ses résultats pour les neuf premiers mois de l'année 2018, confirme ses prévisions et renforce sa trésorerie avec une récente levée de €50m Validation de multiples jalons opérationnels et R&D en bonne [...]
INNATE PHARMA : Number of shares and voting rights of Innate Pharma as at November 1, 2018
08/11/2018
NUMBER OF SHARES AND VOTING RIGHTS OF Innate Pharma AS AT November 1, 2018 Marseille, France, November 8, 2018, 7:00 AM CET Pursuant to the article L. 233-8 II of the French « Code de Commerce » and the article 223-16 [...]
INNATE PHARMA : Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er novembre 2018
08/11/2018
nouveau NOMBRE D'ACTIONS ET DE DROITS DE VOTE d'InnatE Pharma AU 1 er novembre 2018 Marseille, le 8 novembre 2018, 7h00 CET Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l' [...]
Kiadis Pharma strengthens core team with three senior appointments
08/11/2018
Amsterdam, The Netherlands, November 8, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a clinical-stage biopharmaceutical company, today announces that it has [...]
Amphastar Pharmaceuticals, Inc. Announces Reintroduction of Primatene® MIST
08/11/2018
Primatene ® MIST fills unmet medical need as the only FDA approved over-the-counter asthma inhaler RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced [...]
Vital Therapies Announces Third Quarter 2018 Financial Results
08/11/2018
SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company that has been developing ELAD ® , a cell-based therapy targeting the treatment of acute forms of liver failure, [...]
Precision Optics Corporation Schedules First Quarter Conference Call
07/11/2018
GARDNER, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal year 2019 first quarter [...]

Pages